Don't be caught off-guard: Amgen AMGN releases its next round of earnings Thursday. Want to skip the homework and get all the facts in one place? We thought so.
Here is your everything-that-matters guide for Thursday's Q4 earnings announcement after the bell.
Earnings and Revenue
Analysts predict Amgen will report earnings of $3.03 on revenue of $5.83 billion.
In the same quarter last year, Amgen reported earnings per share of $2.89 on sales of $5.95 billion. If the company were to match the current consensus estimate when it reports Thursday, sales would be down 2.26 percent from the same quarter last year.
Here's how the company's reported EPS has compared to analyst estimates in the past:
| Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 |
| EPS Estimate | 3.1 | 3.1 | 3 | 2.79 |
| EPS Actual | 3.27 | 3.27 | 3.15 | 2.89 |
Q4 EPS Estimate: $3.03
Q4 Revenues Estimate: $5 billion
Stock Performance
Shares of Amgen were trading at $191.27. Over the last 52-week period, shares of Amgen are up 23.86 percent.
Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The most common rating by analysts on Amgen stock is a Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Don't be surprised to see the stock move on comments made during its conference call. Amgen's Q4 conference call is scheduled to begin at 5:00 p.m. ET and can be accessed here.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
